In Addition it raises execution hazard due to the fact new builds have to recruit and prepare scarce procedure engineers. If FDA anticipations tighten for info integrity, Merck's scale and high-quality programs must help safeguard continuity. A downside scenario is slower ramp timing that forces higher dependence on external drug https://www.tjcy.com/industry-information/api-vs-fdf-vs-intermediates-what-s-the-difference.html